Vanguard Capital Management
ATOS icon

Vanguard Capital Management’s Atossa Therapeutics ATOS Stock Holding History

Vanguard Capital Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$705K Hold
361,747
– – ﹤0.01% 3628
2026
Q2 		$698K Buy
361,747
+12,651
+4% +$57.7K ﹤0.01% 3656
2026
Q1 		$1.84M Buy
+349,096
New +$2.21M ﹤0.01% 3396

Other funds holding ATOS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $225B AUM
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $273B AUM 15.34% 1-Year Est. Return

Vanguard Capital Management's ATOS Position: Q3 2026 in Review

Vanguard Capital Management held its Atossa Therapeutics (ATOS) position steady in Q3 2026 at 361,747 shares worth $705K. The position accounts for ﹤0.01% of the portfolio, ranked #3628.

Vanguard Capital Management first reported a position in ATOS in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.84M in Q1 2026. 29 funds tracked by Wall St. Rank hold ATOS as of Q3 2026.

  • Vanguard Capital Management held 361,747 shares of Atossa Therapeutics worth $705K as of Q3 2026.
  • Vanguard Capital Management left its Atossa Therapeutics share count unchanged in Q3 2026.
  • Atossa Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3628 holding.
  • Vanguard Capital Management first reported a position in Atossa Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Atossa Therapeutics position peaked at $1.84M in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.